Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9 Gastrointestinal 6 Other hematologic neoplasm 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Dermatologic 1

Conditions

Melanoma 306 Carcinoma, Basal Cell 58 Skin Neoplasms 53 Lymphoma, T-Cell, Cutaneous 37 Breast Neoplasms 31 Uveal Melanoma 29 Neoplasms 27 Lung Neoplasms 26 Carcinoma, Non-Small-Cell Lung 25 Neoplasm Metastasis 24 Keratosis, Actinic 24 Carcinoma, Squamous Cell 21 Carcinoma, Renal Cell 20 Lymphoma 17 Mycosis Fungoides 16 Lymphoma, Large B-Cell, Diffuse 15 Hodgkin Disease 15 Urinary Bladder Neoplasms 14 Sezary Syndrome 14 Pancreatic Neoplasms 14 Lymphoma, Non-Hodgkin 14 Lymphoma, Follicular 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Ovarian Neoplasms 13 Lymphoma, Mantle-Cell 13 Lymphoma, B-Cell, Marginal Zone 13 Colorectal Neoplasms 13 Burkitt Lymphoma 13 Lymphoma, Large-Cell, Immunoblastic 12

Interventions

Cell-Free Nucleic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pathologic Complete Response × Dermatologic × Clear all

NCT02907827 2020-12-17

DW-MRi

Universitair Ziekenhuis Brussel

Phase NA Unknown

Pathologic Complete Response, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡